与年龄相关的斑点退化
Paul Mitchell1, Gerald Liew1, Bamini Gopinath1
1Centre for Vision Research, Department of Ophthalmology, Westmead Institute for Medical Research, University of Sydney, Australia.
年龄相关的黄斑退化 (AMD) 是导致视力丧失的主要原因. 治疗有效地治疗新血管性AMD,但缩性AMD缺乏治疗方法,凸显了预防和再生医学的需求.
科学领域:
- 眼科 眼科
- 遗传学
- 与年龄相关的斑点退化病因
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是不可逆转的视力损伤和失明的主要原因.
- AMD分为早期 (德鲁森,色素变化) 和晚期 (新血管,缩) 阶段.
- 病变发生涉及多因素路径,包括补充,脂质,血管和炎症过程,受遗传学 (CFH,ARMS2) 和生活方式 (吸烟,饮食) 的影响.
研究的目的:
- 审查当前对与年龄相关的黄斑退化 (AMD) 发病和治疗的理解.
- 突出治疗新血管性AMD的进展和治疗缩性AMD的挑战.
- 讨论AMD研究的未来方向,包括预防,个性化医疗和再生疗法.
主要方法:
- 关于AMD病变,风险因素和治疗干预措施的当前文献的审查.
- 对导致AMD发展和进展的遗传和非遗传因素的分析.
- 对抗血管内皮生长因子 (抗VEGF) 治疗和正在进行的临床试验等现有治疗的有效性进行评估.
主要成果:
- 遗传因素 (CFH,ARMS2) 和环境因素 (吸烟,低抗氧化剂摄入量) 在很大程度上影响了AMD的风险.
- 营养补充剂 (,抗氧化剂) 可以减缓AMD的进展.
- 静脉内抗VEGF疗法显著减少了新血管AMD导致的视力损失.
结论:
- 用抗VEGF药物有效治疗新血管性AMD,大大减少视力损伤.
- 目前缺乏经过验证的治疗方法,
- 未来的AMD治疗可能包括加强预防,个性化医疗,新疗法和再生方法.
更多相关视频
08:54Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
相关概念视频
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
The Effect of Aging on Tissues
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
